News + Filings Transactions
|
McCain Tracey L
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/29/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Units | 5k | $0.00 | $0 | | 06/29/2023 |
| 06/14/2023 | ImmunoGen, Inc. | IMGN | Grant | Restricted Stock Unit | 13.1k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | ImmunoGen, Inc. | IMGN | Grant | Stock Option (right to buy) | 19.6k | $0.00 | $0 | | 06/14/2023 |
| 06/06/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 26.2k | $15.19 | $398.5k | | 06/06/2023 |
| 06/06/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 4.4k | $0.00 | $0 | | 06/06/2023 |
| 03/06/2023 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 106 | $44.41 | $4.7k | | 03/06/2023 |
| 03/06/2023 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 3.2k | $45.72 | $147k | | 03/06/2023 |
| 03/01/2023 | Blueprint Medicines Corp | BPMC | Grant | Common Stock | 12.5k | $0.00 | $0 | | 03/01/2023 |
| 03/01/2023 | Blueprint Medicines Corp | BPMC | Grant | Stock Option (Right to Buy) | 25k | $43.15 | $1.1M | | 03/01/2023 |
| 12/30/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 2.8k | $0.00 | $0 | | 12/30/2022 |
| 11/15/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 30k | $0.00 | $0 | | 11/15/2021 |
| 11/15/2022 | ImmunoGen, Inc. | IMGN | Grant | Stock Option (right to buy) | 44k | $5.68 | $249.9k | | 11/15/2021 |
| 09/30/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 2.9k | $0.00 | $0 | | 09/30/2022 |
| 06/30/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 3.1k | $0.00 | $0 | | 06/30/2022 |
| 06/29/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 30k | $9.88 | $296.4k | | 06/29/2022 |
| 06/29/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 5k | $0.00 | $0 | | 06/29/2022 |
| 06/15/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 8.7k | $0.00 | $0 | | 06/15/2022 |
| 06/15/2022 | ImmunoGen, Inc. | IMGN | Grant | Stock Option (right to buy) | 25.6k | $3.37 | $86.1k | | 06/15/2022 |
| 03/31/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 2.9k | $0.00 | $0 | | 03/31/2022 |
| 03/07/2022 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 1k | $56.19 | $58.8k | | 03/03/2022 |
| 03/03/2022 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 1.7k | $60.28 | $100.5k | | 03/03/2022 |
| 03/01/2022 | Blueprint Medicines Corp | BPMC | Grant | Common Stock | 12.5k | $0.00 | $0 | | 03/01/2022 |
| 03/01/2022 | Blueprint Medicines Corp | BPMC | Grant | Stock Option (Right to Buy) | 25k | $61.31 | $1.5M | | 03/01/2022 |
| 12/07/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 4.3k | $97.46 | $421.8k | | 12/07/2021 |
| 12/07/2021 | Blueprint Medicines Corp | BPMC | Exercise | Stock Option (Right to Buy) | 5k | $28.36 | $141.8k | | 12/07/2021 |
| 12/07/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 100 | $95.54 | $9.6k | | 12/07/2021 |
| 12/07/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 572 | $96.38 | $55.1k | | 12/07/2021 |
| 11/03/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 4.2k | $110.74 | $465.1k | | 11/03/2021 |
| 11/03/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 800 | $109.63 | $87.7k | | 11/03/2021 |
| 11/03/2021 | Blueprint Medicines Corp | BPMC | Exercise | Stock Option (Right to Buy) | 5k | $28.36 | $141.8k | | 11/03/2021 |
| 09/23/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 4.8k | $109.80 | $522.9k | | 09/23/2021 |
| 09/23/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 17.3k | $108.78 | $1.9M | | 09/23/2021 |
| 09/23/2021 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 2.9k | $107.75 | $314.7k | | 09/23/2021 |
| 09/23/2021 | Blueprint Medicines Corp | BPMC | Exercise | Stock Option (Right to Buy) | 25k | $28.36 | $709k | | 09/23/2021 |
| 06/29/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 33.2k | $14.33 | $476.3k | | 06/29/2021 |
|
|